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Abstract
Background: Data concerning incidence and prevalence of cancer in the different regions of
Russia have traditionally not been provided on a basis that facilitated comparison with data from
countries in western parts of Europe. The oncological hospital in Arkhangelsk, in co-operation with
Universitetet i Tromsø (Norway), has established a population based cancer registry for
Arkhangelskaja Oblast (AO). AO is an administrative unit with 1.3 million inhabitants in
northwestern Russia. The aim of this investigation was to assess the content and quality of the AO
cancer registry (AKR), and to present the site-specific cancer-incidence rates in AO in the period
1993–2001.
Methods: The population in this study consisted of all individuals registered as residents of AO.
All new cancer cases in the period 1993 – 2001, registered the AKR, were included in the study
(ICD-10: C00-C95, except for C77-78). The annual gender and age-group-specific population
figures were obtained from the AO statistics office.
Results: A total of 34 697 cases of primary cancers were included. The age-adjusted (world
standard) incidence rate for all sites combined was 164/100 000 for women and 281/100 000 for
men. The highest incidence was for cancer of the trachea, bronchus and lung (16.3% of all cases),
whereof 88.6 % of the cases were among men. Among women, cancer of the breast constituted
15.9 percent of all cases. The age-adjusted incidences of the most frequent cancer sites among men
were: lung (77.4/100 000); stomach (45.9); rectum (13.4); oesophagus (13.0); colon (12.2); bladder
(11.6); and prostate cancer (11.1). Among women they were: breast (28.5); stomach (19.7); colon
(12.2); and ovary cancer (9.0).
Conclusion: Our findings confirm and strengthen the indication that the incidences of stomach,
larynx, liver, pancreas, prostate, colon, bladder and melanoma cancer are quite different in male
populations in Russia compared to many other European countries. Among women, most major
cancer types, except stomach, appear to be relatively low in Russian populations. The AKR
provides quality data for estimations and insight to the cancer incidence in a northern Russian
population, and we consider the reported incidence rates to reflect the cancer situation in AO well.
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Background
Data concerning incidence and prevalence of cancer in the
Soviet Union (USSR) and Russia have traditionally not
been provided on a basis that facilitated comparison with
data from countries in western parts of Europe [1]. This
was due to differences in routines and procedures for
reporting, registration and diagnostics [2], as well as to a
lack of information that described the procedures. Today,
the cancer registry in St Petersburg is the only regional
cancer registration in Russia that has been recognised by
the European Network of Cancer Registries to fulfil inter-
national standards, but efforts have been made to stand-
ardise the system within Russia [2]. In 1997, the
oncological hospital (OD) in Arkhangelsk and the Uni-
versitetet i Tromsø (Norway) started the planning of a
population based cancer registry for Arkhangelskaja
Oblast (AO). The systematic registration started in 1999,
and the objective was to register all cancer cases in AO
from 1993 and onwards.
A verifiable cancer registry that covers the population of
AO will not only give valuable insight into the cancer inci-
dence in Russia, but also into the incidence in a northern
population that has been relatively homogenous both
ethnically and socio-economically. The aim of this inves-
tigation was to assess the content and quality of the AO
cancer registry (AKR), and to present the site-specific can-
cer-incidence rates in AO in the period 1993–2001.
Methods
Context
AO is an administrative unit with 1.3 million inhabitants.
It covers 587 000 km2 (larger than France) north of the
60th latitude in North-West Russia (Figure 1). The unit
consists of 26 boroughs, whereof 6 are cities. In addition,
there is an autonomous region, Nenets, in the north. Until
the late 1990s, twelve percent of the land area was for use
by military units only (Nenets not included) [3]. The
administrative centre is the city Arkhangelsk, which
houses 28 percent of the population. The main industries
are pulp and paper mills, and heat and power plants. Gas
and oil industry predominate in Nenets.
The population of AO grew during the 1980s and reached
a historical high of 1 576 000 inhabitants in 1991. In the
years that followed, the mortality and migration
increased, and the birth rate went down [4,5]. In year
2000, the largest ethnic groups were Russians (92 per-
cent); Ukrainians (3.4); Byelorussians (1.3); Komi (0.5);
and Nenets (0.5), and 74 percent of the population
resided in urban areas [5]. In 1999, the life expectancy in
AO was 71.1 years for women and 58.0 years for men,
which was a decrease from 74.7 and 64.0, respectively, ten
years earlier [5]. Life expectancy was higher in urban than
in rural areas, but lower than in the neighbouring regions
in North-West Russia [5,6]. The most frequent causes of
death were connected to the circulatory system (54%);
accidents (16%); and tumours (14%) [4].
The only oncological hospital (OD) in AO is located in
the city Arkhangelsk, where 35 of the about 50 practising
oncologists in 2002 worked. About one-half of the bor-
oughs had at least one oncologist. The boroughs without
an oncologist did instead have a medical worker who was
responsible for cancer recording and reporting, but this
person had, in general, no contact with the cancer
patients. Every Russian citizen has the right to receive
medical care without service fees. When a patient is
referred to a district or central hospital, the local hospital
might cover the travel expenses if financial resources are
available. But more often than not, the patients must
cover these expenses themselves. The latter is also true for
persons seeking a doctor or a hospital within his/her
home borough. All forms of cancer treatment are availa-
ble in the city Arkhangelsk. Radiotherapy is only available
there, while surgery is carried out in every hospital where
there is a surgeon qualified to perform the appropriate
surgery. The same is true for chemotherapy, but this
North-western Russia [17] Figure 1
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treatment can only be given after the patient has been
examined at the OD, and under supervision by them.
The pathology department at the OD, which is the only
one in AO, has had separate laboratories for cytology and
histopathology. The latter had 3 pathologists, and proc-
essed 35 000 surgical pathology specimens annually. The
department had available to them a complete version of
the WHO International Histological Classification of
Tumours in Russian. Immunohistochemistry was estab-
lished at the AO Main Hospital in 2001, in co-operation
with the hospital in Tromsø. The pathology department
and the main hospital co-operate closely, and frequently
consult each other when faced with difficult cases.
Study population
The population in this study consists of all individuals
registered as residents of AO. All new cancer cases in the
period 1993 – 2001 registered in the AKR were included
in the study (International Classification of Disease, ver-
sion 10 (ICD-10): C00-C95, except for C77-78 (secondary
malignant neoplasm)), and the data obtained were anon-
ymous. The estimated incidence rates of cancer were
adjusted for age using the world standard (5-year age-
group intervals) [7]. In instances where an individual was
diagnosed with cancer more than once during a six-
month period, only the first diagnosis was included in the
rate estimates. When a registered diagnosis of cancer sub-
sequently showed not to be cancer, the case was not
included. The annual gender and age-group-specific pop-
ulation figures for AO were obtained from the federal sta-
tistics office of AO. In the calculations of cancer incidence
for year 2001, population figures for year 2000 were used
for the age groups older than 69 years.
Cancer reporting and the Arkhangelsk Cancer Registry
The cancer reporting and registration is founded in legis-
lation. The oncologist/doctor who determines a cancer by
diagnosis fills in a report form, and is required to submit
it to the OD within three days. Notification has been
obligatory since the 1960s. The form contains guidelines
for proper fill-out. For instance, the diagnosis is to be
spelled out in words. If the local oncologist/doctor is
uncertain about the diagnosis, the patient is to be referred
to a larger hospital or the OD. For patients who are treated
locally by a doctor who is not an oncologist, a medical
report is submitted when a patient is discharged. The
medical-report form also includes a field for description
of the treatment and course of the disease. Both ICD-
codes and words are used in the description. When the
OD receives a medical report with incoherence between
the two, the OD systematically contacts the local hospital
for clarification.
In the submitted report, it is noted whether the patient is
a resident of another borough than where he/she was
diagnosed/treated. When a resident of AO is diagnosed
elsewhere in Russia, the diagnosing hospital forwards the
report to the OD in AO, and vice versa when non-AO res-
idents are diagnosed in AO. Thus, reports of cancer cases
among students and conscripts are forwarded to the
regions in Russia where they have permanent residence.
When a person dies, a doctor submits a medical docu-
ment to the local administrative office, which issues a
death certificate and a certificate about identity and citi-
zenship (no burial can take place before a death certificate
is issued). The certificates are forwarded to the AO statisti-
cal office. The cause of death is established either on the
basis of the deceased's anamnesis, or by pathological or
forensic examination. Only one cause of death is recorded
on the certificate, and the statistical office defines the ICD-
code. Should the recorded cause of death be changed
later, a notification is submitted to both the administra-
tive and statistical offices. The family of the deceased can
object to, or demand, a post-mortem examination. If a
pathological examination reveals cancer, then both the
stage and metastasis are made note of on the certificate.
Medical employees from the OD visit the statistical office
monthly to pick up information about cancer deaths. The
OD then requests information about the revealed individ-
uals from the registrar's office. This information is
checked against the AKR to find out whether the specific
case already has been registered. The information from
the registrar also reveals whether an individual has
changed surname between the time of diagnosis and time
of death.
The OD sends an annual report to the ministry in Moscow
about cancer incidence and mortality in AO. The report
also includes the number of cases that was verified histo-
logically and clinically. The OD is required to verify unver-
ified cases within two years.
Cancer registration
In 1996, a computer programme was put into use in the
clinical work due to a directive from the health ministry.
Data about cancer cases had until then only existed on
paper-based patient records that were organised in an
archive. The work to set up the AKR started in 1998. A
data-entry programme was made using Access®, and all
reported cases of cancer since 1993 were registered retro-
spectively. From 2001, the cancer cases were registered as
soon as reports were received. The computer programme
for the registration has been revised and improved twice
since the registration started. Simultaneously, the infor-
mation registered and the number of database fields
included was modified (see Table 1). The electronic can-
cer registry has been administered and run by the OD.BMC Cancer 2005, 5:82 http://www.biomedcentral.com/1471-2407/5/82
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The registration in the AKR was based on the information
obtained on submitted form(s), and was updated if
revised information was reported later. The oncologist in
charge of the AKR routinely checked that reported histol-
ogy and diagnosis were in accordance, and set the ICD-
code if it was missing. The diagnosis was registered both
in words and with a three character ICD-code. ICD-9
codes were used in registration of cases from the period
1993 – 99, and ICD-10 from year 2000. Thus, in the reg-
istered ICD-9 codes it was not possible to separate cancers
in the sigmoid junction and rectum, so in the present
study sigmoid junction was included in the rate estimate
of rectum cancer – and not of colon cancer.
The data registered about each case are presented in Table
1. Not all of the data items were considered a must. But
Table 1: Data items registered in the Arkhangelsk Cancer Registry
Data registered Comments
Number at registration card
Surname, given name, patronymic In separate fields from 1995
Gender C
Residence (urban or rural) C
Date of birth For the period 1995–99 the year was registered
Rajon (borough) of residence C
Home address From 2000 also home oblast included
Occupation C
Date when registered as sick (by general health system)
Result of treatment / patient's status Last known, at the end of the year. C
Date of last status
Clinical health group at the time of registration e.g. Will be cured, etc. From 1995 C
Clinical health group at the end of year From 1995 C
Descriptive diagnosis
Cancer diagnosis 1 Only for the years 93–94 C
Diagnosis by ICD-9 code 1 Only for the years 1993–99 C
Diagnosis by ICD-10 code 1 Only for the years 1993–94, 2000- C
How the tumour was detected Registered if method was autopsy or only obtained from death 
certificate
C
Stage C
TNM From 1995
Method of verification of diagnosis Morphologic, cytologic, X-rays, endoscopy, isotopic, ultra sound, 
computer tomography, operation, only clinical, or unknown
C
Date of diagnosis From 1995
Reason for late diagnosis From 2000 C
Morphological code C
Main cancer site (when more than one site) For internal use clinically
Histological structure of tumour Classification for internal use. From 1995 C
Synchronic tumour Yes/no. Only in period 1995–99
Localisation of cancer (side of body) Right/left C
Information about treatment For the period 1995–s99
Method of treatment, if radical From 2000 C
Institution where diagnose was determined From 2000 C
Institution where patient is under observation Medical institution observing the patient C
Metastasis? Yes/no. Only in period 1995–99
Number of tumours From 2000 C
Date of last contact with patient From 2000
Cause of death From 1995. Including code of cause from 2000 C
Date of death From 1995
Pathological examination Yes/no. From 2000 C
Nationality From 1995 C
Date cancer report received From year 2000
C = The field in the AKR database was formatted. I.e. data entry was restricted to possible or certain values.
1 Three fields in the database, but in the period 1993–94 the values appeared in all three fields when data were entered in one of them.BMC Cancer 2005, 5:82 http://www.biomedcentral.com/1471-2407/5/82
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the following information has been obligatory (and
inquired for if missing on the submitted form): name, pat-
ronymic, surname, gender, date of birth, place of resi-
dence, diagnosis, date of diagnosis, histology, stage
according to the TNM-classification, method of diagnosis
and treatment, place of treatment, and whether the
patient is alive or dead. If dead, the following information
was required: date of death, cause of death, and whether a
pathological examination had been conducted. The iden-
tification of an individual was based on name, surname,
patronymic and birth date.
The AKR registered whether a tumour was first revealed
through autopsy, or if a case was first reported through a
death certificate. The outcome of the cancer disease was
also registered. The patients' last known status was
updated annually. The updating was based on a final-
treatment report, or on the patient's registration card if
treated at the OD. One of the following eight possible out-
comes was noted: alive; dead due to the treatment, the
cancer, or another cause; treated basal cell carcinoma (and
5 years have passed without a relapse); moved to another
region of Russia or abroad; the diagnosis showed to not be
cancer; or unknown. The method of diagnosis was regis-
tered as one of the following: only clinical; histological;
cytological; isotopic; endoscopic; x-ray; electronic
tomography; ultra sound; surgery; or unknown. There
were tick-off boxes on the report form for six of the meth-
ods, while the others usually were noted if used.
The registration procedures in the AKR included some
internal quality control systems. After entry; the name,
age, borough and diagnosis were checked visually against
the received information to ensure correctness. The data-
base programme used since year 2000 automatically rec-
ognises whether an individual has been registered before
if the following data are identical: name; patronymic; sur-
name; gender and birth date. In addition, the following
logical checks are embedded in the programme: 1) that
the birth date precedes the date of diagnosis in terms of
real time; 2) that the date of diagnosis precedes the date of
treatment/surgery; 3) that gender-specific diagnoses are
logical in terms of registered gender. The latter was previ-
ously done by visual checks. Visual checks were also done
to look for contradictions between diagnosis and histo-
logical verification and stage, respectively. Furthermore,
most data-entry fields are formatted, which ensures that
impossible or undefined values cannot be entered. In
fields where a numerical value represents some defined
information, the field is linked to a drop-down window
that depicts and explains the range of possible values that
can be entered. The fields that are formatted are depicted
in Table 1.
Quality and content assessment
To assess the completeness and correctness of the AKR,
two of the authors (JAL and AV) visited two district hospi-
tals (in Severodvinsk and Kholmogory) to check whether
the living cancer patients in their files had been registered.
The two hospitals were given a one-day notice before the
control. The researchers were given full access to the can-
cer-patient files. In Severodvinsk 42 out of 723 and in
Kholmogory 61 of 396 journals of living cancer patients
were randomly selected and looked for in the AKR data-
base. In addition, in Severodvinsk the following specific
items were checked against the registry for each of the
selected journals: name; year of birth; diagnosis; and date
of diagnosis. These data were read aloud from the hospital
files by JAL and checked in the database records by AV.
The assessment revealed that six of the cancer patients
residing in Severodvinsk were not registered. One of the
42 could not be checked because the person was not a res-
ident of the borough. Out of the 59 who were residents of
Kholmogory, none were missing in the AKR. Thus, overall
6 out of 100 (6 %) cancer cases belonging to the popula-
tion were not registered (95% CI: 1.3–10.7%).
The data obtained in Severodvinsk were also used to
assess the data-entry error in the AKR. In two of the
checked files (5.7%), the diagnosis registered differed
from the diagnosis in the journal. Both were recorded as
ICD-10 C19 in the files, but registered as C20 and C50 in
the AKR. One surname was incorrectly registered (1%),
while for three cases there was a discrepancy in year of
birth (3%). The registered year of diagnosis was in accord-
ance with the data in all the checked journals. One record
was missing the year of diagnosis and one other was miss-
ing the birth year, but the data were recorded in the
patients' files.
The data-entry error rate was also assessed by checking the
consistency between registered gender and gender-specific
diagnoses (ICD-9: 174, 175, 180, 182, 183, 185 and 186)
(this check was embedded in the computer programme
from year 2000). There was a discrepancy between regis-
tered gender and diagnosis in one out of 4294 records
(one case with the diagnosis ICD 174, female breast can-
cer, was registered as a male). The quality of the AKR was
further assessed by looking at distributions of data; the
proportions of missing values; the presence of non-logical
values; and the proportion of registered cases whose case
information was obtained from a death certificate.
In September 2001, Helge Stalsberg, a professor in mor-
phology at the University of Tromsø and head doctor of
the Department of Pathology at the University Hospital,
was invited to Arkhangelsk to review the histological-diag-
nostic practise. Stalsberg was given full access to the mate-
rial, including protocols concerning the diagnoses givenBMC Cancer 2005, 5:82 http://www.biomedcentral.com/1471-2407/5/82
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Table 2: Cancer in Arkhangelskaja Oblast 1993–2001. Number of new cases and age-adjusted incidence rates per 100 000, by primary 
site and gender
Males Females
ICD-9 ICD-10 Number
new cases
Incidence
rate
Number
new cases
Incidence
rate
Lip 140 C00 266 4.2 95 0.7
Tongue 141 C01-02 109 1.6 27 0.2
Gum 143 C03 35 0.5 20 0.2
Floor of mouth 144 C04 88 1.3 5 0.1
Palate 145 C05-06 66 1.0 24 0.2
Salivary glands 142 C07-08 29 0.4 39 0.4
Tonsil / oropharynx 146 C09-10 168 2.4 42 0.4
Nasopharynx 147 C11 24 0.3 17 0.2
Periform sinus and other unspecified 149 C12, C14 58 0.8 4 0.0
Hypopharynx 148 C13 117 1.7 7 0.1
Oesophagus 150 C15 814 13.0 414 3.3
Stomach 151 C16 2880 45.9 2232 19.7
Small intestine 152 C17 32 0.5 27 0.3
Colon 153 C18 753 12.2 1346 12.2
Rectosigmoid junction, rectum and anus 154 C19-21 805 13.4 858 7.8
Liver 155 C22 325 5.1 221 2.0
Gallbladder and other unspecified 156 C23-24 82 1.4 183 1.5
Pancreas 157 C25 590 9.2 566 4.9
Other digestive organs 159 C26 2 0.0 4 0.0
Nasal cavity and paranasal sinuses 160 C30-31 58 0.8 49 0.5
Larynx 161 C32 472 6.9 33 0.4
Trachea, bronchus and lung 162 C33-34 5011 77.4 646 5.8
Pleura, thymus, mediastinum and heart 163,164 C37-38,C45 53 0.8 43 0.4
Other respiratory 165 C39 1 0.0 0 0.0
Bone, connective tissue, Kaposi's sarcoma 170 C40-41,C46 120 1.9 78 0.8
Melanoma of skin 172 C43 169 2.5 291 3.0
Other skin 173 C44 856 14.4 1478 12.9
Nervous system 192 C47,C70,C72 19 0.3 21 0.3
Retroperitoneum and peritoneum 158 C48 86 1.4 117 1.1
Connective and other soft tissue 171 C49 102 1.5 115 1.2
Breast 174,175 C50 20 0.3 2689 28.5
Vulva, vagina. other female genital organ 184 C51-52, C57 0.0 161 1.4
Cervix uteri 180 C53 0.0 790 8.4
Corpus uteri 182 C54 0.0 779 8.1
Uterus. unspecified 179 C55 0.0 3 0.0
Ovary 183 C56 0.0 854 9.0
Placenta 181 C58 0.0 11 0.2
Penis and other male genital organs 187 C60, C63 31 0.5 0.0
Prostate 185 C61 611 11.1 0.0
Testis 186 C62 110 1.5 0.0
Urinary tract, except bladder 189 C64-66,C68 592 9.1 574 5.7
Bladder 188 C67 737 11.6 223 1.8
Eye 190 C69 33 0.5 46 0.6
Brain 191 C71 303 4.4 289 3.7
Thyroid gland 193 C73 98 1.4 457 5.1
Adrenal and other endocrine glands 194 C74-75 27 0.4 18 0.2
Other or unspecified site 195,199 C76,C80 257 4.0 188 1.8
Hodgkin's disease 201 C81 184 2.7 158 2.1
Non-hodgkin's lymphoma 200 C82-83,C85 198 3.3 157 1.7
Other lyphoid and histiocytic tissue 202 C84,C96 18 0.3 10 0.1
Multiple myeloma 203 C88-90 70 1.1 96 0.9
Lymphoid leukaemia 204 C91 213 3.5 187 2.0BMC Cancer 2005, 5:82 http://www.biomedcentral.com/1471-2407/5/82
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for each case. He selected a priori to review the slides of the
20 most recent cases of each of the following cancer types:
lung; stomach; colon; breast; and testes. Without consult-
ing the protocol, he set a diagnosis one by one. His diag-
noses were subsequently compared with the protocolled
diagnoses. For testis cancer, only six cases were reviewed,
as only six cases had been diagnosed so far that year. Thus,
in total 86 cases were reviewed – all from 2001. The qual-
ity of the histological sections was considered adequate.
There was full agreement concerning presence of invasive
carcinoma in all cases of stomach and testis cancer. For
both breast and colon cancer there were agreements for 19
of 20 slides. One of each was in disagreement on in situ
versus invasive. For lung cancer, 2 of 20 were in disagree-
ment on in situ dysplasia versus no dysplasia. The micro-
tomes and microscopes possessed by the laboratory were
found fully adequate for histological-diagnostic work.
Results
A total of 35 224 cases of cancer, diagnosed in the period
1993 – 2001, were registered in the AKR. For 13 of the
cases, the diagnosis had later been changed to non-cancer,
while 42 cases were benign, in-situ carcinoma or second-
ary cancers. In addition, 472 registered cases had been
revealed through autopsy. Thus, 34 697 cases were
included in the calculations of cancer incidence. Of these,
95.2 percent had never had cancer before, and men
constituted 51.3 percent. The number of new cases varied
from 3559 in 1996 to 4153 in year 2000. In terms of age,
the mode was 67 years, the median 63 years, and the range
0 – 99 years.
The annual proportion of diagnoses that were verified his-
tologically was around 60 percent, while the proportion
verified cytologically increased from 15 to around 20 per-
cent in the studied period. The highest proportion verified
histologically was for rectal cancer (81.4 %), while breast
cancer was the cancer type most likely to be verified cyto-
logically (36.8 %). (These figures include cases that were
registered based on death certificates). The highest pro-
portion verified by one of these two methods was in the
age group 20 – 29, and the proportion was lower the older
the age group.
The age-adjusted incidence rate for all sites combined was
164/100 000 for women and 281/100 000 for men. The
highest incidence was cancer of the trachea, bronchus and
lung (16.3% of all cases), whereof 88.6 % of the cases
were among men. The second most frequent was stomach
cancer (14.7%). Among women, cancer of the breast con-
stituted 15.9 percent of all cases. The age-adjusted gender-
and site-specific incidence rates are presented in Table 2.
The cancer sites with the highest rates among men were:
lung (77.4/100 000); stomach (45.9); rectum (13.4);
oesophagus (13.0); and colon (12.2). Among women
they were: breast (28.5); stomach (19.7); and colon
(12.2). Some trends of cancer incidence are presented in
Figures 2, 3, 4, 5, 6.
Discussion
According to MacLennan (IARC), the following informa-
tion is considered basic in a population-based cancer reg-
istry: date of diagnosis; basis of diagnosis; site of primary
tumour; morphology; behaviour of tumour; source of
information; place of residence; ethnic group; and per-
sonal information sufficient to ensure the recognition of
an individual when the same person is reported more
than once to the registry [8]. All these items were regis-
tered in the AKR, except for ethnicity. Ethnicity could be
of interest to register in AO due to the Nenets indigenous
population (0.5% of total population), but this was made
unattainable when the Russian Federation implemented
the use of "Russian" as nationality for all in identity doc-
uments. No unique identification number existed in Rus-
sia, but the identification of the individual was fulfilled in
the AKR by registering the full name, gender and birth
date.
Quality
The AKR is a comprehensive registry in terms of important
information about each cancer case, and had few data-
entry errors. The pathology department at the OD works
according to the classifications of the WHO International
Histological Classification of Tumours, and the diagnostic
procedures, equipment and skills were found to be fully
adequate.
The correctness of incidence rates is influenced by the
completeness of cover. The numerator in the rate esti-
mates is deflated if not all cases of cancer in the official
resident population were captured by the health system,
and/or if the AKR did not receive reports about all diag-
nosed cases. The denominator, on the other hand, is
incorrect if the health system of AO covered more or fewer
Myeloid leukaemia 205 C92 94 1.4 138 1.5
Monocytic leukaemia 206 C93 5 0.1 8 0.1
Other specified leukaemias 207 C94 21 0.3 25 0.3
Unspecified leukaemias 208 C95 26 0.4 39 0.4
Table 2: Cancer in Arkhangelskaja Oblast 1993–2001. Number of new cases and age-adjusted incidence rates per 100 000, by primary 
site and gender (Continued)BMC Cancer 2005, 5:82 http://www.biomedcentral.com/1471-2407/5/82
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people than the official population figures. The results of
the controls carried out in Severodvinsk and Kholmogory
indicate that the submission of cancer reports to the AKR
was not fully complete, and that the reporting varied from
district to district. There was no apparent explanation for
the difference in reporting between the two clinics, which
both had an oncologist. Incomplete reporting has also
been found to hamper the estimations of cancer incidence
in established systems with a long tradition of population
based cancer registration, such as in Norway [9]. On the
other hand, a fully complete cancer registry is
inconceivable.
The AKR is a population-based cancer registry that is
meant to cover the population of AO. Conscripts and stu-
dents from elsewhere were not included in the official
population figures, and cancer cases among them were
not registered. There were two sub-groups of the official
population of which some members were likely to sur-
vive, or die, with an undiagnosed cancer, and thereby
contribute to an underestimation of incidence rates;
namely, the indigenous Nenets and the poor elderly. The
former mainly live in the north, and those among them
who lived traditionally on the tundra as herders and hunt-
ers were less likely to seek or receive medical care from the
public health care system. Poverty in Russia increased
markedly in the 1990s – especially among elderly.
Although health services in Russia were free and without
service fees, the transport to the doctor or hospital usually
had to be paid by the individual. Distances in rural areas
are vast, and travelling was often uncomfortable and rela-
tively expensive. Persons of age 80 years or older had the
opportunity to transport without paying by inquiring for
a requisition in advance. However, it is not unlikely that
an increasing proportion of the elderly died from, or with,
Age-adjusted, gender-specific incidence of cancer, all sites combined, in Arkhangelskaja Oblast Figure 2
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an undiagnosed cancer. Nevertheless, the age-specific
incidence rates, all sites combined, in the older age groups
did not decline within the study period.
Other sub-groups that were included in the official popu-
lation figures, but possibly not fully reported to the AKR,
were professional military personnel and railway and
shipyard workers. These groups had their own health care
privileges or systems that did not sort under the health
authorities in AO, but directly under the state. This meant
that patients who could not be treated within their own
health system were sent to Moscow for treatment. Report-
ing was also done directly to Moscow, but this ended in
the late 1990s for shipyard and railway workers. The OD
had contact with the patients from these groups only if
referred to them, and subsequently these patients would
also be included in the AKR. The immediate families of
these workers could also use the same health care system.
The shipyard workers were located the city of Severod-
vinsk (population 230 000), which was a closed city due
to the construction of nuclear and naval vessels at the
shipyard. Figures about the number of workers in each of
these groups were not publicly available, so the number of
missing cases in the AKR from these two groups of
workers is not readily estimated. But presumably the
reduced allocation of funds after the disintegration of the
USSR had the effect that fewer workers were sent to Mos-
cow for cancer treatment. Furthermore, the retirement age
for shipyard workers was as low as 45 years for women
and 50 years for men, meaning that the workers were
retired before they were in the highest risk groups in terms
of age for most cancer types. The retirement age for male
military personnel was 55 years.
Another group of concern in terms of population coverage
was emigrants. People moving from AO to somewhere
else in Russia were likely to register change of address, and
if not, the report forms, if diagnosed elsewhere, would
have been forwarded to AO. But quite a few people have
emigrated to other former Soviet republics or other
Trend of age-adjusted colon and stomach cancer among men and women in Arkhangelskaja Oblast Figure 3
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countries, and these people had no incentive or require-
ment to register. According to official figures there was a
net emigration from AO of about 6000 people per year on
average in the study period [10]. However, the first census
since the disintegration of the USSR, which was held dur-
ing the autumn of 2002, revealed that the actual popula-
tion of AO was about 90 000 people lower than the
official population figures, and that 2/3 of the deficit was
among men [11]. Thus, the net emigration had been more
than twice the official figures – on average. Based on age
in 2002, the largest population discrepancies for men
were in the age groups 35–39 and 60–64, and in the age
groups 10–14 and 60–64 for women. The underestima-
tion in the reported overall incidence rates for the whole
study period should then be less than four percent due to
this population factor. But since the population discrep-
ancy varied with age group and gender, the underestima-
tion will be of a higher magnitude for some cancer types
and lower for others. The discrepancy between the official
population-figures used in the present rate estimations
and the real population size was presumably accumula-
tive over time since the disintegration of the USSR. Hence,
the influence of an inflated denominator on the estimated
incidence rates was likely small in the early years of the
study period, and more profound in the rates for 2000
and 2001.
The findings and notions discussed above indicate that
the reported rates are underestimations, especially among
men. However, the relative magnitudes of the site-specific
cancer incidences within a gender would only have been
affected by underreporting of cases if the population sub-
groups discussed above were unusually prone, or less dis-
posed, to certain types of cancer. Cancers related to the
Trend in age-group specific cancer incidence among women in Arkhangelskaja Oblast, all sites combined Figure 4
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elderly were presumably of most concern in this perspec-
tive, but in the shipyard there might have been exposure
to asbestos.
The proportion of cancer cases that was not captured by
the health system, or diagnosed cases not caught by the
AKR, can be estimated by calculating the annual propor-
tion of cases among not-previously-registered individuals
that were obtained from death certificates. The complete-
ness of cover may also be evaluated by comparing the inci-
dence rates of the different cancer types. The number of
cases that were registered based on death certificate was
419 (2.4%) among men and 538 (3.0%) among women.
The proportion varied from <0.6 percent in the years
1993–94 and 2000–01 to 5 percent in the period 1995–
99. The actual proportion-level is an indication of how
well the system works, and if the system worked consist-
ently the proportion should have been fairly constant.
Thus, the ability of diseased people to seek examination
and treatment, and/or the function of the system, appears
to have been impaired during the years of severe eco-
nomic hardship. A study by Shkolnikov et al found that
cancer deaths in the older age groups were under-recorded
in Russia – especially in rural areas [12]. In Norway, the
proportion of registered cases obtained from death certif-
icates was 2.6 percent for both genders in 1993 [7].
The analysis revealed that almost 80 percent of all cases
were verified histologically or cytologically. In the former
USSR as a whole, 69.8 percent of the diagnoses were veri-
fied microscopically in 1989, and the proportion of cases
verified varied from 62.4 to 81.3 percent between the
Trend in age-group specific cancer incidence among men in Arkhangelskaja Oblast, all sites combined Figure 5
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different republics or oblasts within the union [1]. In the
neighbouring country Norway, 86 percent of all cases
since 1953 have been verified histologically [13].
Cancer incidence
The age-adjusted cancer incidence among men, all-sites
combined, was similar to the incidence in Norway. But
among women the incidence was more than 30 percent
lower in AO [13]. However, one should be careful in
comparing the incidence rates in Russia with western
countries since the competing risks of disease and death
were different. The magnitude of the large difference in
cancer incidence between men and women in AO was
likely not due to an underestimation of rates, as the men-
tioned possible causes of underestimation mainly con-
cerned men. For most cancers, the site-specific incidences
found in AO were comparable both in magnitude and rel-
ative magnitude to rates for Russia in 1990, as reported by
the International Agency for Research of Cancer (IARC)
[14]. The total age-adjusted incidence among men was
284/100 000 in Russia vs. 267 in AO, while 170 vs. 151/
100 000 among women (ICD-9: 173 was not included in
these calculations). In comparison with the IARC-
reported incidence, the site-specific incidence in AO
among men was higher for oesophagus, and lower for lar-
ynx and testis cancer. Also women had a higher incidence
of oesophagus cancer in AO, but the incidences of cancer
of the lung, breast and cervix uteri were lower [14]. Com-
pared to the incidence of female genital cancers in St.
Petersburg, the incidences of corpus uteri and ovary can-
cer were lower in AO, while the incidence of cervix uteri
cancer was of similar magnitude [15]. Interestingly, the
rate of stomach cancer was relatively high and colon can-
cer low, just as in Norway 30–40 years ago when the rates
were quite different from today [16].
The age distribution in AO, as in Russia, is different than
the world standard population. Compared to the world
standard (and most Western-European populations),
there were relatively few older men and children below 10
years of age, as well as a small World-War II generation
(age 50 – 59 in the study period). On the other hand, the
post-war generation was relatively large (age 35 – 49).
Thus, the distribution in AO was pear-shaped, in contrast
to the pyramid-shape of the world standard population
and the fairly evenly distribution of most Western-Euro-
pean populations. This means that the age adjustment of
the incidence rates in AO contributed to an over-estima-
tion of the cancer types that were most likely to develop in
the age groups that were relatively small, and vice versa,
compared to the actual burden of those cancers in the
society.
The reported incidence rates in AO contribute to the dis-
cussion and generation of hypotheses concerning the role
of different life-style and environmental factors in the
aetiology of different cancer types. The AKR provides data
for estimations and interesting insight to the cancer inci-
dence in a northern Russian population. Using the registry
for further investigations into district and age-group-spe-
cific differences in cancer incidence would shed addi-
tional light on the concerns and questions surrounding
environmental and life-style aspects and cancer.
Conclusion
We believe that the reported incidence rates reflect the
cancer situation in AO well. Our findings then confirm
and strengthen the indication that the incidence of
melanoma of the skin and cancers of the stomach, larynx,
liver, pancreas, prostate, colon, and bladder are quite dif-
ferent in male populations in Russia than, for instance, in
Norway. Among women, most major cancer types, except
stomach, appear to be relatively low in Russian
populations.
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